We assessed the bioavailability of orange juice (poly) phenols by monitoring urinary flavanone metabolites and ring fission catabolites produced by the action of the colonic microbiota. Objective: Our objective was to identify and quantify metabolites and catabolites excreted in urine 0-24 h after the acute ingestion of a (poly)phenol-rich orange juice by 12 volunteers. Design: Twelve volunteers [6 men and 6 women; body mass index (in kg/m 2 ): 23.9-37.2] consumed a low (poly)phenol diet for 2 d before first drinking 250 mL pulp-enriched orange juice, which contained 584 mmol (poly)phenols of which 537 mmol were flavanones, and after a 2-wk washout, the procedure was repeated, and a placebo drink was consumed. Urine collected for a 24-h period was analyzed qualitatively and quantitatively by using high-performance liquid chromatography-mass spectrometry (HPLC-MS) and gas chromatography-mass spectrometry (GC-MS). Results: A total of 14 metabolites were identified and quantified in urine by using HPLC-MS after orange juice intake. Hesperetin-Oglucuronides, naringenin-O-glucuronides, and hesperetin-3#-O-sulfate were the main metabolites. The overall urinary excretion of flavanone metabolites corresponded to 16% of the intake of 584 mmol (poly)phenols. The GC-MS analysis revealed that 8 urinary catabolites were also excreted in significantly higher quantities after orange juice consumption. These catabolites were 3-(3#-methoxy-4#-hydroxyphenyl)propionic acid, 3-(3#-hydroxy-4#-methoxyphenyl)propionic acid, 3-(3#-hydroxy-4#-methoxyphenyl)hydracrylic acid, 3-(3#-hydroxyphenyl)hydracrylic acid, 3#-methoxy-4#-hydroxyphenylacetic acid, hippuric acid, 3#-hydroxyhippuric acid, and 4#-hydroxyhippuric acid. These aromatic acids originated from the colonic microbiota-mediated breakdown of orange juice (poly) phenols and were excreted in amounts equivalent to 88% of (poly)phenol intake. When combined with the 16% excretion of metabolites, this percentage raised the overall urinary excretion to w100% of intake. Conclusions: When colon-derived phenolic catabolites are included with flavanone glucuronide and sulfate metabolites, orange juice (poly)phenols are much-more bioavailable than previously envisaged. In vitro and ex vivo studies on mechanisms underlying the potential protective effects of orange juice consumption should use in vivo metabolites and catabolites detected in this investigation at physiologic concentrations.
INTRODUCTION
Citrus fruits are rich source of flavanones, which are a subgroup of flavonoids, and oranges (Citrus sinensis) and their derivatives such as orange juice contain mainly hesperetin-7-O-rutinoside (hesperedin) and naringenin-7-O-rutinoside (narirutin). Prospective studies have revealed that the consumption of either oranges or orange juice is associated with reduced risk (19%) of ischemic stroke and acute coronary events in women (1) with an improvement of vascular function (2) . In addition, a reduction of plasma lipid peroxidation has been observed in healthy women (3) . These effects have been attributed mainly to the flavanone content of oranges. It has been reported that hesperetin and naringenin intakes reduce risk of cerebrovascular disease and asthma (4) . Furthermore, the consumption of hesperetin-7-Orutinoside for a period of 3 wk by subjects with metabolic syndrome has been shown to improve endothelial function, reduce circulating biomarkers of inflammation, and favorably alter lipid profiles (5) .
Animal and in vitro studies have shown that hesperetin and naringenin exhibit a wide range of biological activities, such as antioxidant, anti-inflammatory (6) , and antitumor activities (7, 8) and also are able to reduce plasma markers of endothelial dysfunction in high-cholesterol-fed rats (9) , atherosclerosis plaque progression in high cholesterol-fed rabbits (10) and mice (11) , and improved insulin sensitivity in diabetic rat models (12, 13) .
In order for orange flavanones to exert their health effects in vivo, it is essential that they are bioavailable and absorbed from the gastrointestinal tract into the circulatory system. Humanbioavailability studies have shown that flavanones are absorbed as glucuronide and sulfate conjugates in amounts corresponding to only 5-15% of intake (14) (15) (16) (17) . Consumption studies with ileostomists who consumed a (poly)phenol-rich drink that contained 45.3 mmol hesperetin-3-O-rutinoside, detected 3 hesperetin-O-glucuronides, one of which was hesperetin-7-Oglucuronide, and a hesperetin-O-glucuronide-O-sulfate in urine, with 0-24 h excretion that amounted to 1.6 mmol, which is equivalent to 3.5% of intake (18) . This amount is much less that the 11.9% of intake of hesperetin metabolites excreted by healthy volunteers with a functioning colon after drinking the same (poly)phenol-rich beverage (15) . These figures indicate w30% of hesperetin metabolites are absorbed in the small intestine and the remaining w70% are absorbed in the colon. Plasma pharmacokinetic profiles of 2 hesperetin-O-glucuronides, one of which is hesperetin-7-O-glucuronide, obtained in healthy volunteers, exhibited a high nanomole per liter peak plasma concentration 3.724.4 h after intake in keeping with this proposal (14, 15) .
Flavanones that reach the large intestine as well as being absorbed as sulfate and glucuronide metabolites are also broken down by the colonic microbiota that produce an array of phenolic catabolites (19) . These catabolites are absorbed into the circulatory system before renal excretion and, as such, are an integral part of the overall bioavailability equation of dietary flavanones and may play a role in the protective effects of dietary flavanones (20, 21) .
Building on existing research findings and by using a pulpenriched orange juice, the current study investigated the urinary excretion of flavanone metabolites and their colonic microfloramediated breakdown products. The study focused on the cumulative excretion of these compounds in urine because it provides a more-accurate quantitative assessment of absorption than do plasma pharmacokinetics. Although plasma profiles can yield useful information, they are not an accurate quantitative guide of absorption because the presence of flavonoid metabolites and catabolites in the circulatory system is transient as they are treated as xenobiotics and are rapidly removed from the bloodstream via renal excretion (21) .
SUBJECTS AND METHODS

Chemicals and materials
Methanol and ethyl acetate were obtained from Rathburn Chemicals. Formic acid, N-methyl-N-(trimethylsilyl) trifluoroacetamide, pyridine, 2#,4#,5#-trimethoxycinnamic acid, 4-hydroxybenzoic acid, ferulic acid, 4#-hydroxyphenylacetic acid, 3#-methoxy-4#-hydroxyphenylacetic acid, hippuric acid, 3-(3#-methoxy-4#-hydroxyphenyl)propionic acid, and 3-(3#-hydroxy-4#-methoxyphenyl)propionic acid were purchased from Sigma-Aldrich. 4#-Hydroxyhippuric acid was obtained from Bachem (UK) Ltd. Hesperetin-7-O-rutinoside (hesperedin), 4#-O-methyl-naringenin-7-O-rutinoside (didymin), and narigenin-7-O-rutinoside (narirutin) were acquired from Extrasyntheses. 3-(3#-Hydroxyphenyl) hydracrylic acid, hesperetin-7-O-glucuronide, naringenin-4#-O-glucuronide, and naringenin-7-O-glucuronide were purchased from Toronto Research Chemicals Inc. Deuterated methanol (99.8% pure) was obtained from Goss Scientific Instruments Ltd. HPLC-grade methanol was purchased from Fisher Scientific.
Study design
The study was approved by the University of Glasgow Royal Infirmary Ethics Committee (project 2011017) and registered with BioMed Central Ltd (http://www.controlled-trials.com; ISRCTN04271658). Twelve healthy volunteers (6 men and 6 women) between 23 and 60 y old and with BMI (in kg/m 2 ) from 23.9 to 37.2 were recruited. Volunteers were nonsmokers and not taking medication. All subjects were informed about the purpose of the study and gave written informed consent before their inclusion in the trial. Volunteers were required to follow a diet low in (poly)phenolic compounds for 48 h before the study and 24 h after supplementation and avoid fruit, vegetables, high-fiber products, and beverages such as tea, coffee, fruit juice, and wine. On the day of consumption, after an overnight fast, each subject drank 250 mL pulp-enriched orange juice. A light breakfast that consisted of white bread, cheese, ham, and milk was provided 2 h after orange juice intake. After a washout period of 2 wk, volunteers ingested 250 mL placebo drink. After supplementation, all urine was collected over 5 time periods (0, .0-2, .2-5, .5-10, and .10-24 h). The volume of urine excreted was measured, and aliquots were stored at 280 8C before analysis by using high-performance liquid chromatographyphotodiode array-mass spectrometry and gas chromatographymass spectrometry (GC-MS) 4 .
Extraction of orange juice
The pulp-enriched orange juice and placebo drink used in the feeding study were extracted by using the following procedure. Briefly, 5-mL aliquots of juice, which were previously homogenized by using an Ultraturrax homogenizer, were extracted twice with 5 mL methanol for 2 min and centrifuged at 2800 3 g for 15 min at 4 8C. The pellet was extracted in the same manner with 2 mL methanol. The 2 supernatant fluids were pooled and reduced to dryness in vacuo, redissolved in 6 mL 50% aqueous methanol, and stored at 280 8C before analysis.
Analysis of orange juice and urine by using HPLC with photodiode array and MS detection Samples were analyzed by using a Surveyor HPLC system comprised of an HPLC pump, a photodiode array detector scanning from 200 to 600 nm and an autosampler operating at 4 8C (Thermo Electron Corp). Reverse-phase separations were carried out by using a 150 3 4.6-mm inside diameter 5-mm 10-A C 18 Kinetex column (Phenomenex) maintained at 40 8C and eluted at a flow rate of 1.0 mL/min with a 1) 60-min gradient of 5-50% methanol in 0.1% aqueous formic acid for juice extracts and 2) 25-min gradient of 15-45% methanol in 0.1% aqueous formic acid for urine samples. After passing through the flow cell of the photodiode array detector, the column eluate was split, and 0.2 mL/min was directed to an LCQ Advantage ion-trap mass spectrometer fitted with an electrospray interface operating in negative-ionization mode (Thermo Electron Corp). The capillary temperature was 300 8C, heath gas was 60 units, auxiliary gas was 40 units, and source voltage was 3 kv. Identifications were based on full-scan, data-dependent MS scanning from 100 to 800 m/z, MS-MS fragmentation, and comparisons of the retention time and absorption l max with available standards.
(Poly)phenols in orange juice were quantified on the basis of chromatographic peak areas acquired at 290 nm and expressed relative to standards of hesperetin-7-O-rutinoside, naringenin-7-O-rutinoside, 4#-O-methyl-naringenin-7-O-rutinoside, and ferulic acid. Hesperetin-O-glucosyl-O-rutinoside was quantified as hesperetin-7-O-rutinoside equivalents, and naringenin-O-glucosyl-O-rutinoside and eriodictyol-7-O-rutinoside (eriocitrin) were quantified as naringenin-7-O-rutinoside equivalents. The quantification of metabolites in urine was carried out by using HPLCmass spectrometry (HPLC-MS) in selected ion monitoring mode by reference to ferulic acid, hesperetin-7-O-glucuronide, naringenin-4#-O-glucuronide, or naringenin-7-O-glucuronide calibration curves. Remaining metabolites, for which authentic standards were not available, were quantified in hesperetin-7-O-rutinoside and naringenin-7-O-rutinoside equivalents.
All calibration curves were prepared from reference compounds dissolved in methanol at concentrations ranging from 0.1 to 100 ng/mL. A linear response was obtained for all the standard curves as checked by using a linear regression analysis (R 2 . 0.999). Limits of detection (range: 0.1-0.9 ng), limits of quantification (1.7-3.0 ng), and the precision of the assay (as the coefficient of intraassay variation, which ranged from 2.8% to 5.0%) were considered acceptable allowing the quantification of flavonoids and their metabolites.
Analysis of urine by gas chromatography with MS detection
Urine samples were prepared as described by Roowi et al (19) with some modifications. Briefly, 1 mL of urine sample was added to 3 mL 0.2 mol/L HCl that contained 60 mg of 2#,4#,5#-trimethoxycinnamic acid as an internal standard. Styrene divinylbenzene solid-phase extraction cartridges (Strata SDB-L 200 mg; Phenomenex.) were used for sample purification. Before loading with the acidified urine samples, the cartridge was activated with 3 mL ethyl acetate and conditioned with 3 mL methanol followed by 3 mL 0.1 mol/L HCl. The acidified sample was added, the cartridge was washed with 3 mL 0.1 mol/L HCl, and the cartridge was dried with nitrogen for 20 min after which phenolic catabolites were eluted with 3 mL ethyl acetate. The ethyl acetate eluate was transferred to an amber glass vial and reduced to dryness under a stream of nitrogen gas at 35 8C. The dried extract was silylated by using 300 mL of a mix of pyridine and N-methyl-N-(trimethylsilyl) trifluoroacetamide (1:4, vol:vol) heated at 80 8C for 20 min on a heating block. Samples were cooled in vacuo in a desiccator before analysis by using GC-MS.
Derivatized phenolic catabolites in urine were analyzed on a 6890 gas chromatograph equipped with a 7683S autosampler, a 5973 mass spectrometer (Agilent Technologies), and a ZB-5MS Zebron 30 m 3 0.25 mm 3 0.25-mm (inside diameter) capillary column (Phenomenex) with helium as a carrier gas (1.2 mL/min). GC-MS conditions were as follow: injection volume (1 mL), split ratio (1:25), initial temperature of 408C and raised to 1608C at 208C/min, 2008C at 1.58C/min, and 2508C at 108C/min, and a final temperature of 3008C at 408C/min held for 5 min. The injector temperature was maintained at 2208C, MS transfer line was 1508C, and ion source was 2308C. Mass spectra were scanned at m/z 50-470 with an ionization energy of 70 eV. Phenolic compounds were identified according to their retention time and mass spectra of authentic standards. When standards were not commercially available, an identification was achieved though the integrated National Institute of Standards and Technology mass spectral library, with confidence $95% Quantification was based on calibration curves of the ratio between the target ion (m/z) of the standard of interest and the target ion of the 2#,4#,5#-trimethoxycinnamic acid internal standard.
Statistical analysis
Results are expressed as means 6 SEMs of 2 measurements obtained from urine samples from 12 volunteers. Data were assessed for homogeneity of variances by using Levene's test and subjected to a nonparametric 1-factor analysis of variance (Friedman's test for related samples) with the SPSS Statistics program (version 22; IBM). Differences were considered to be significant at P , 0.05.
RESULTS
Identification and quantification of (poly)phenols in orange juice
The HPLC-MS identified 8 compounds (see Supplemental  Table 1 under "Supplemental data" in the online issue) in quantifiable amounts in the pulp-enriched orange juice. These compounds were flavanones naringenin-7-O-rutinoside (114 mmol/ 250 mL), hesperetin-7-O-rutinoside (329 mmol), 4#-O-methylnaringenin-7-O-rutinoside (also known as isosakuranetin-7-Orutinoside and didymin) (19 mmol), naringenin-7-O-rutinoside-4#-O-glucoside (51 mmol) hesperetin-7-O-rutinoside-3#-Oglucoside (19 mmol), and eriodictyol-7-O-rutinoside (5 mmol) along with the flavone apigenin-6,8-C-diglucoside (vicenin-2) (42 mmol) and hydroxycinnamate ferulic acid-4#-O-glucoside (5 mmol) (see Supplemental Figure 1 under "Supplemental data" in the online issue for structures). In total, this amounted to 584 mmol/250 mL of the 8 (poly)phenolic compounds of which 537 mmol/250 mL were flavanones. The placebo drink ingested by volunteers did not contain detectable quantities of any of the (poly)phenols that were present in the pulp-enriched orange juice.
Identification of flavanone metabolites in urine
After acute intake of 250 mL orange juice, 14 flavanone metabolites were identified or partially identified by an HPLC-MS analysis of urine collected from 12 volunteers over a 24-h postingestion period. See Supplemental Figure 2 and Supplemental Table 2 
Quantification of flavanone and flavone metabolites in urine
Quantitative data on the excretion of flavanones metabolites in urine 0-24 h after orange juice intake are presented in Table 1 . No metabolites were detected in urine collected over a 12-h period before ingestion of the juice. Likewise, no metabolites were detected in the 0-24-h urine of any of the volunteers after the consumption of the placebo drink.
Hesperetin-O-glucuronides were the main flavanone metabolites to appear in urine after orange juice consumption followed by naringenin-O-glucuronides and hesperetin-3#-Osulfate. Hesperetin-O-diglucuronides and hesperetin-O-sulfate-O-glucuronide were excreted in lower amounts. Small quantities of naringenin-O-diglucuronides, hesperetin-O-sulfate-O-glucoside, and eriodictyol-O-sulfate were also quantified ( Table 1 ). There was a 61 6 7-mmol excretion of hesperetin metabolites. A total of 21 6 2 mmol naringenin metabolites was excreted. The sole eriodictyol metabolite, which is an eriodictyol-O-sulfate, was excreted in much lower amounts at 0.26 6 0.15 mmol.
There was no excretion of metabolites of 4#-O-methylnarigenin-7-O-rutinoside. Likewise, no urinary metabolites of the ingested 42 mmol of the flavone apigenin-6,8-C-diglucoside were detected, which was anticipated in view of the extremely low bioavailability of C-linked flavanone and dihydrochalcone glycosides noted in feeding studies with rooibos teas (22) .
Urinary excretion of phenolic catabolites after orange juice intake
Urine collected 12 h before and 0-2, .2-5, .5-10, and .10-24 h after the ingestion of 250 mL orange juice or placebo drink by volunteers was analyzed by using GC-MS, which identified 10 phenolic catabolites (see Supplemental Figure 4 and Table 3 under "Supplemental data" in the online issue). Quantitative data on the average level of excretion of catabolites are presented in Table 2 . There was minimal excretion in the initial 0-2-h collection period. In samples collected thereafter, 4 compounds [3-(3#-hydroxy-4#-methoxyphenyl)hydracrylic acid, 3-(3#-hydroxy-4#-methoxyphenyl)propionic acid (dihydroisoferulic acid), 3-(3#-methoxy-4#-hydroxyphenyl)propionic acid (dihydroferulic acid), and 3#-hydroxyhippuric acid] appeared in urine after orange juice consumption but not after intake of the placebo drink. 3-(3#-hydroxyphenyl)hydracrylic acid, 4-hydroxybenzoic acid, 3-methoxy-4-hydroxyphenylacetic acid, 4-hydroxyphenylacetic acid, hippuric acid, and 4#-hydroxyhippuric acids were detected in urine excreted after the ingestion of both drinks. However, the excretion of 3-(3#-hydroxyphenyl)hydracrylic acid, 3-methoxy-4-hydroxyphenylacetic acid, hippuric acid, and 4#-hydroxyhippuric acid was significantly higher after orange juice intake ( Table 2 ) (see Supplemental Figure 5 under "Supplemental data" in the online issue for structures). These results indicated that these compounds, together with those that appeared only after orange juice intake, were derived directly (or indirectly in the case of the hippuric acids) from colonic microflora-mediated flavanone catabolism. Note that 3-(3#-hydroxy-4#-methoxyphenyl)propionic acid, which is likely to be a breakdown product of hesperetin, was detected, for the first time to our knowledge, in human urine after orange juice intake.
Note that, in the absence of a reference compound, the identification of 3-(3#-hydroxy-4#-methoxyphenyl)hydracrylic acid after purification by HPLC was confirmed by the nuclear mass resonance spectroscopy analysis (see Supplemental Figure  6 under "Supplemental data" in the online issue for an explanation). The purified sample was subsequently used for the quantifications of 3-(3#-hydroxy-4#-methoxyphenyl)hydracrylic acid by using GC-MS.
The 0-24-h excretion of phenolic catabolites after the ingestion of orange juice and the placebo drink is summarized in Table 3 . 3-(3#-Hydroxy-4#-methoxyphenyl)hydracrylic acid is a key indicator of orange juice consumption because it was excreted in substantial amounts (72 mmol) but was absent in urine collected after the consumption of the placebo. The 2 propionic acids and 3#-hydroxyhippuric acid were similarly absent in placebo urine and accumulated after orange juice intake but to a much lesser extent than was 3-(3#-hydroxy-4#-methoxyphenyl)hydracrylic acid. Although present in trace amounts after intake of the placebo, orange juice consumption was associated with a .10-fold higher excretion of 3-(3#-hydroxyphenyl)hydracrylic acid. The baseline excretion of hippuric acid was high at 232 mmol and increased significantly to 610 mmol after orange juice intake. The number of volunteers who showed a significant increase in excretion ranged from 4 to 11 of 12 volunteers which presumably was a reflection of the varying microflora of volunteers (Table 3) . The overall amounts of key phenolic catabolites, excluding hippuric acid, that were excreted in urine in significantly increased amounts after orange juice intake were compared with their excretion after ingestion of the placebo drink intake in Table 4 . Most excretion was observed between .5-10 and .10-24 h after orange juice administration.
DISCUSSION
In the feeding study by Borges et al (18) in which ileostomists ingested a (poly)phenol-rich drink, the analysis of ileal fluid indicated that, in healthy volunteers with a functioning colon, substantial amounts of hesperetin-7-O-rutinoside passed from small to large intestines where, after cleavage of the rutinose moiety, the hesperetin would be subjected to phase II metabolism and absorbed into the portal vein as sulfated and glucuronide conjugates. In addition, a portion of the hesperetin undergoes colonic microbiotamediated ring fission and yields low molecular weight phenolic compounds, which also enter the circulatory system, where some of the compounds may undergo additional metabolism in the liver and kidney before renal excretion. 4 Values that increased significantly after orange juice supplementation (P , 0.05) were obtained by using Friedman's test.
In the current study, the excretion of hesperetin and narigenin glucuronide and sulfate metabolites occurred mainly 2-10 h after ingestion of orange juice (Table 1) , which was in keeping with earlier findings that flavanones are absorbed in both the small and large intestines (15, 18) . The excretion of hesperetin metabolites corresponded to 17.5% of the total hesperetin intake, whereas naringenin metabolites were excreted in amounts equivalent to 12.7% of ingested naringenin. The excretion of eriodictyol-Osulfate was 5.2% of eriodictyol-7-O-rutinoside intake. This result indicated that eriodictyol with a 3#,4#-dihydroxy B ring was absorbed less effectively than the 4#-monohydroxylated naringenin. This effect is similar to that of anthocyanins whereby the pelargonidin is absorbed more readily than corresponding cyanidin glycosides (14, 23, 24) . The amount of excretion of hesperetin metabolites compared with naringenin indicated that the methylation of 4#-hydroxyl group may have slightly enhanced absorption. The combined excretion of flavanones metabolites at 83 6 10 mmol was equivalent to 16% of intake (Table 1) The overall amounts of phenolic catabolites, excluding hippuric acid, excreted in urine in significantly increased amounts after orange juice intake are compared with their excretion after ingestion of the placebo drink intake in Table 4 . Note that, over the 24-h collection period, the amount of these phenolic catabolites excreted after drinking the placebo was 5.6 mmol, and with the consumption of orange juice, this amount increased by 135 to 141 mmol, which corresponding to 23% of (poly)phenolic intake. The addition of the 135 mmol to the 83 mmol hesperetin and narigenin glucuronide and sulfate metabolites made a total of 37% of the 584 mmol (poly)phenol intake.
The urinary amount of hippuric acid was not included in the calculated 37% recovery. The quantity of hippuric acid excreted in 0-24-h urine was 232 mmol after the consumption of the placebo compared with 610 mmol after the ingestion of the orange juice. The 2 figures were significantly different (P , 0.05) ( Table 3) . Exactly how much of the 378-mmol increase in hippuric acid (Table 3) , which is primarily of hepatic origin being formed from glycination of benzoic acid (25) , was derived from the orange juice (poly)phenols was difficult to ascertain because of the high person-to-person variation in amounts produced coupled with the high baseline amounts, which were a consequence of hippuric acid also being derived from other compounds in the body unrelated to orange juice intake (25) (26) (27) (28) . If hippuric acid was included in the calculation, the overall flavone and flavanone recovery increased from 37% to w100%. Although high, this was clearly an approximation and a moreaccurate estimate is unlikely to be obtained until feeds with its main potential precursor in the juice (ie, naringenin) are carried out with the flavanone labeled with either 13 C or 14 C in A and B rings. This method would enable an HPLC-MS analysis to distinguish between hippuric acid derived from naringenin and that produced by other unrelated pathways.
When only urinary flavanone glucuronide and sulfate metabolites are analyzed, flavanones, like most other dietary flavonoids, have only a low bioavailabilty. This report establishes that, when colonderived phenolic and aromatic acids are included in the calculation, it is evident that flavanones are highly bioavailable with a recovery w100% of the ingested bolus as urinary metabolites and catabolites. This result is in keeping with data obtained in a human feeding study with [ (29) . Anthocyanins are considered to be very poorly absorbed with typically ,1% of intake being excreted in urine as the parent compound or glucuronide and sulfate metabolites degradation. However, in the study with [ 13 C 5 ]cyanidin-3-O-glucoside, which took into account metabolites and colonic catabolites as well as 13 CO 2 output and fecal products, the ,1% recovery increased to w50%, which showed that cyanidin-3-O-glucoside is also subject to extensive metabolism and catabolism and was absorbed much-more extensively than previously envisaged (29) .
An additional point of importance is that in vitro studies with cell-based test systems intended to investigate mechanisms by which flavonoids and related compounds might exert protective effects should not use parent dietary compounds but, instead, should use their metabolites and catabolites at physiologic doses that correspond to concentrations at which they occur in vivo. In this context, Chanet et al (30) investigated the impact of naringenin and hesperetin metabolites on monocyte adhesion to TNF-a-activated human umbilical vein endothelial cells and gene expression. At a concentration of 2 mmol/L, hesperetin-3#-O-sulfate, hesperetin-3#-O-glucuronide, and naringenin-4#-Oglucuronide significantly attenuated monocyte adhesion. These effects could have been a consequence of the modulation of genes involved in atherogenesis, such as those involved in inflammation, cell adhesion, and cytoskeletal organization and could be one of the mechanisms through which flavanone-rich diets might protect the human vascular system (30).
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